Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism

@article{Cesareo2014EffectsOA,
  title={Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism},
  author={Roberto Cesareo and Enrico Di Stasio and Fabio Vescini and Giuseppe Campagna and Roberto Cianni and Valerio Pasqualini and Federica Romitelli and Franco Grimaldi and Silvia Manfrini and Andrea Palermo},
  journal={Osteoporosis International},
  year={2014},
  volume={26},
  pages={1295-1302}
}
No data on the pharmacological treatment of normocalcemic hyperparathyroidism (NPHPT) are available. We treated 30 NPHPT postmenopausal women with alendronate/cholecalciferol (treated group) or vitamin D alone (control group). Over 1 year, bone mineral density (BMD) increased significantly in treated group, but not in control group. Both treatments did not affect serum or urinary calcium. Normocalcemic primary hyperparathyroidism (NPHPT) is defined by normal serum calcium and consistently… CONTINUE READING
4 Citations
42 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 42 references

a worldwide problemwith health consequences

  • MF Holick, Chen TC Vitamin D deficiency
  • Am J Clin Nutr 87:1080S–1086S 1302 Osteoporos…
  • 2015
1 Excerpt

Similar Papers

Loading similar papers…